A role for insulin-like growth factor binding protein (IGFBP)-2 in DNA repair and chemoresistance in breast cancer cells

Alaa A M Mohammedali*, Kalina M Biernacka*, Rachel M Barker*, Jeff M. P. Holly*, Claire M Perks*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

Abstract

A role for insulin-like growth factor binding protein-2 (IGFBP-2) in mediating chemoresistance in breast cancer cells has been demonstrated, but the mechanism of action is unclear. This study aimed to further investigate the role of IGFBP-2 in the DNA damage response induced by etoposide in MCF-7, T47D (ER+ve) and MDA-MB-231 (ER-ve) breast cancer cell lines. In the presence or absence of etoposide, IGFBP-2 was silenced using siRNA in the ER positive cell lines, or exogenous IGFBP-2 was added to the ER negative, MDA-MB-231 cells. Cell number and death were assessed using trypan blue dye exclusion assay, changes in abundance of proteins were monitored using western blotting of whole cell lysates and localisation and abundance were determined using immunofluorescence and cell fractionation. Results from ER positive cell lines demonstrated that upon exposure to etoposide, loss of IGFBP-2 enhanced cell death, that was associated with a reduction in P-DNA-PKcs and an increase in γH2AX. Conversely, with ER negative cells, the addition of IGFBP-2 in the presence of etoposide resulted in cell survival, an increase P-DNA-PKcs and a reduction in γH2AX. In summary, IGFBP-2 is a survival factor for breast cancer cells that is associated with enhancement of the DNA repair mechanism.
Original languageEnglish
Article number2113
Number of pages21
JournalCancers
Volume16
Issue number11
DOIs
Publication statusPublished - 31 May 2024

Structured keywords

  • ICEP

Keywords

  • IGFBP-2
  • DNA damage and repair
  • chemotherapy
  • DNA-PKcs
  • breast cancer

Fingerprint

Dive into the research topics of 'A role for insulin-like growth factor binding protein (IGFBP)-2 in DNA repair and chemoresistance in breast cancer cells'. Together they form a unique fingerprint.

Cite this